Paclitaxel delivery systems: the use of amino acid linkers in the conjugation of paclitaxel with carboxymethyldextran to create prodrugs.
about
Recent progress in the development of polysaccharide conjugates of docetaxel and paclitaxelDoxorubicin-incorporated polymeric micelles composed of dextran-b-poly(DL-lactide-co-glycolide) copolymer.In vitro assessment of a novel polyrotaxane-based drug delivery system integrated with a cell-penetrating peptideDrug delivery with carbon nanotubes for in vivo cancer treatmentProspects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs.Design, synthesis and applications of hyaluronic acid-paclitaxel bioconjugates.Macromolecules as taxane delivery systems.Hyaluronic acid-coated, prodrug-based nanostructured lipid carriers for enhanced pancreatic cancer therapy.Delivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivoIncreased paclitaxel cytotoxicity against cancer cell lines using a novel functionalized carbon nanotube.Characterization of human cytochrome P450 isoforms involved in the metabolism of 7-epi-paclitaxel.Luteinizing hormone-releasing hormone peptide tethered nanoparticulate system for enhanced antitumoral efficacy of paclitaxel.A paclitaxel prodrug with bifunctional folate and albumin binding moieties for both passive and active targeted cancer therapy.
P2860
Q27010654-F36BB179-DEA8-4315-BB04-275A7D22D9F6Q35122756-BBA060FE-CA9A-4EE9-939F-41B8E93BE650Q36397995-C588C83C-B5B1-4D84-BCCA-688D3C4A19D6Q36925878-DB705553-04DA-4832-8F39-315516D1D72EQ36985913-6AE3291A-3E08-44DE-81A5-C892B7CDE884Q37096500-0AEFF128-2AE2-42D7-A819-C1F503D4ED3EQ37818236-BC8CEE36-9D9A-4525-B19F-36578BB9985AQ38750556-270C2920-3CEA-4071-B192-6A919C3BAAEDQ38867245-89F68DD6-DDA9-4854-8092-871D9DEF4CB6Q39545490-B289D56B-26AE-46D2-8965-A6CB51268C8EQ46059077-5F233D6F-9207-41FB-B034-A0F09FA48417Q52880516-3056705E-C4D9-46BA-B525-8C57B438E16BQ54958677-6662773E-EF3B-4B9E-BB6C-C57EDCEDBA25
P2860
Paclitaxel delivery systems: the use of amino acid linkers in the conjugation of paclitaxel with carboxymethyldextran to create prodrugs.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Paclitaxel delivery systems: t ...... hyldextran to create prodrugs.
@ast
Paclitaxel delivery systems: t ...... hyldextran to create prodrugs.
@en
type
label
Paclitaxel delivery systems: t ...... hyldextran to create prodrugs.
@ast
Paclitaxel delivery systems: t ...... hyldextran to create prodrugs.
@en
prefLabel
Paclitaxel delivery systems: t ...... hyldextran to create prodrugs.
@ast
Paclitaxel delivery systems: t ...... hyldextran to create prodrugs.
@en
P2093
P356
P1476
Paclitaxel delivery systems: t ...... hyldextran to create prodrugs.
@en
P2093
Hiroshi Kuriyama
Masahiro Kajiki
Shu-ichi Sugahara
To-ru Kobayashi
P304
P356
10.1248/BPB.25.632
P577
2002-05-01T00:00:00Z